Quantcast

Latest autoimmune disease Stories

2014-03-31 16:27:04

Health Insurance Claim Data Suggests Value of Screening BOSTON, March 31, 2014 /PRNewswire-USNewswire/ -- Patients with an autoimmune disease have a 3.8-fold increased risk of developing epilepsy, according to a new population-level study from Boston Children's Hospital based on health insurance claim data. The study, published online March 31, 2014 in JAMA Neurology, is the largest to date to look at the association between autoimmune disease and epilepsy without a recognized...

2014-03-26 08:29:10

GAITHERSBURG, Md., March 26, 2014 /PRNewswire/ -- The HealthWell Foundation, an independent non-profit providing nationwide financial assistance to insured Americans with high out-of-pocket medication expenses, today announced the launch of a new fund to assist patients suffering from chronic idiopathic urticaria. The fund provides copayment assistance to eligible patients to help ease the burden of medical costs to treat the condition. Urticaria is a condition that typically...

2014-03-12 04:21:02

CARMEL, Calif., March 12, 2014 /PRNewswire/ -- Autoimmune diseases are one of the top 10 leading causes of death in female children and women in all age groups up to 64 years of age. While common immunosuppressant treatments frequently lead to devastating long-term side effects, the NIH estimates up to 23.5 million Americans suffer from autoimmune disease and that number is rising. Life is a significant challenge for those suffering from autoimmune disorders. Many continue to struggle...

2014-03-07 12:25:28

TBG and TNIB join forces to address the critical need for quality treatments to combat chronic, life-threatening diseases in developing countries around the world MINNEAPOLIS and ORLANDO, Fla., March 7, 2014 /PRNewswire/ -- The Brewer Group, Inc. ("TBG") a global investment advisory firm, today announced a new strategic partnership with TNI BioTech, Inc. ("TNIB") (OTCQB: TNIB), a biotechnology company pioneering the development of innovative therapies for autoimmune diseases by...

2014-03-06 12:27:02

ORLANDO, Fla., March 6, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC: TNIB) announced today that it has formed a new subsidiary, Cytocom, Inc., for the purpose of developing Low Dose Naltrexone (LDN) and Met-enkephalin (MENK). TNI BioTech has spent the last year developing a manufacturing and distribution network for sale of LDN into emerging nations and has had discussions with the FDA and EMA to begin clinical trials in the United States. The Company has considered whether to...

2014-02-11 16:25:01

ORLANDO, Fla., Feb. 11, 2014 /PRNewswire/ -- TNI BioTech Inc., (OTCQB:TNIB) a biotechnology company pioneering the development of?innovative therapies for autoimmune diseases by combating these fatal diseases through the activation and modulation of the body's immune system, today announced that it received notification from the U.S. Securities and Exchange Commission ("SEC") that the SEC has completed its review of the Company's Form 10 registration statement, effectively clearing...

2014-01-22 23:21:15

The Paleo Approach: Reverse Autoimmune Disease and Heal Your Body shows the scientific evidence that proves the correlation between autoimmune disorders and diet/lifestyle. Altanta, GA (PRWEB) January 22, 2014 Sarah Ballantyne, PhD, respected health blogger, autoimmune expert and dedicated mom delivers the first-ever complete guidebook to help manage autoimmune disease through Paleo diet and lifestyle in: The Paleo Approach: Reverse Autoimmune Disease and Heal Your Body. In this...

2014-01-22 08:28:34

Patent Provides Coverage for Lpath's Anti-S1P Antibody in the Treatment of a Wide Variety of Ocular Disorders, Including Wet AMD SAN DIEGO, Jan. 22, 2014 /PRNewswire/ -- Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, received official notification from the U.S. Patent and Trademark Office that the company has been issued another key patent supporting its iSONEP(TM) program. The newly issued U.S. patent, No. 8,614,103, is entitled,...

2014-01-13 12:27:53

SEATTLE, Jan. 13, 2014 /PRNewswire/ -- Adaptive Biotechnologies announced today a biomarker discovery agreement facilitated by the Johnson & Johnson Innovation Center in California. Under the agreement, Adaptive will use its patented immune profiling assay, immunoSEQ(TM), to enable an in-depth characterization of the immune response to diseases being studied and select immunology and oncology drugs being developed by Janssen Research & Development, LLC (Janssen). The...

2014-01-07 23:01:17

A 2.5-Day Summit Providing Groundbreaking Approaches to Treating Patients With Interrelated Autoimmune Conditions Malvern, PA (PRWEB) January 07, 2014 The Interdisciplinary Autoimmune Summit (IAS) is pleased to announce the Keynote Address to be presented by Noel R. Rose, MD, PhD, Professor of Pathology, Professor of Molecular Microbiology and Immunology, Director, Johns Hopkins Center for Autoimmune Disease Research, The Johns Hopkins Medical Institutions. On Friday, June 20, 2014 at...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related